# The Third Britton Chance International Symposium on Metabolic Imaging and Spectroscopy

> **NIH NIH R13** · UNIVERSITY OF PENNSYLVANIA · 2024 · $16,500

## Abstract

The Third Britton Chance International Symposium on Metabolic Imaging and Spectroscopy
Project Summary
Elucidation of metabolic processes is critical for a wide range of fundamental physiological research and for
clinical applications associated with cancer, diabetes, cardiovascular-, skeletomuscular-, lung-, neurological-,
and neurodegenerative-diseases, and brain function. Many researchers aim to elucidate metabolic processes,
but they do so with the perspective of a particular biomedical field or imaging technology. Unfortunately, few
opportunities exist for researchers dedicated to metabolic imaging and spectroscopy to convene outside of their
communities. Thus, the goal of this proposed conference is to bring together clinicians, biomedical scientists,
and physical scientists from different communities to collaboratively explore key topics in metabolic imaging and
spectroscopy, especially as it relates to biomedical and clinical applications. Emphasis will be placed on clinical
translation, latest technical developments, and multi-modal metabolic imaging/spectroscopy. The conference
program is aligned with the missions and interests of several NIH institutes including the NIBIB, NCI, NINDS,
NIA, and NIDDK. Specifically, the conference will feature: 1) In-depth methodology sessions that focus on
developing tools for the study of biological/physiological processes such as hemodynamics, glycolysis,
mitochondrial bioenergetics, hypoxia and redox state; these processes are common underlying factors in many
diseases; 2) Application sessions focused on the connections between metabolism and pathology in cancer,
brain, muscle, and visceral organs including heart/lung/liver/kidney; 3) Panel discussions to identify critical
research questions, innovations, clinical translation needs, and regulatory issues (e.g., IRB, IND, etc.); 4) A
workshop on career development and grant writing to help investigators, particularly new investigators; 5)
Enhanced participation of junior researchers (students, postdocs, research associates, and early-stage
investigators) facilitated by travel stipends, flash-highlight talks, poster awards, round-table small group
discussions with senior researchers; 6) Enhanced diversity by encouraging participation of minorities and women
with dedicated travel scholarships. Dr. Chance was a founding father of both in vivo NMR Spectroscopy and
Biophotonic Imaging/Spectroscopy, and he was a pioneer in the study of metabolism and physiology. He remains
inspirational for many researchers working in different subfields, due to his emphasis on cross-disciplinary
research exchange, innovation, and clinical translation, and his efforts to build the scientific community by
tirelessly educating and helping students and young researchers. Branding this event as a “Britton Chance”
symposium will help increase conference visibility within this diverse research community; indeed, >200 people
participated in each of the first two symposiums (2013, ...

## Key facts

- **NIH application ID:** 11000644
- **Project number:** 1R13EB035926-01A1
- **Recipient organization:** UNIVERSITY OF PENNSYLVANIA
- **Principal Investigator:** LIN Z LI
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $16,500
- **Award type:** 1
- **Project period:** 2024-07-15 → 2025-07-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11000644

## Citation

> US National Institutes of Health, RePORTER application 11000644, The Third Britton Chance International Symposium on Metabolic Imaging and Spectroscopy (1R13EB035926-01A1). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/11000644. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*